Drugs Made In America Acquisition DMAAU
NASDAQ DMAAU
$10.79 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition Corp. (DMAAU) Debt Ratio (2024 - 2025)

Drugs Made In America Acquisition's (DMAAU) quarterly Debt Ratio came in at 0.0 in Q1 2025, down 99.98% on a QoQ basis from 1.2 in Q4 2024.

Drugs Made In America Acquisition Corp. (DMAAU) Debt Ratio (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 2 years of Debt Ratio data on file, last reported at 0.0 in Q1 2025.

  • Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.0 (changed N/A YoY) and the FY2024 annual result came in at 1.2, changed N/A from the prior year.
  • Debt Ratio eased to 0.0 in Q1 2025, from 1.2 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.2 in Q4 2024 to a low of 0.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 0.00
Dec 31, 2024 1.20